Samuel Riccitelli

Samuel D.
Riccitelli is the Lead Independent Director at OrthoPediatrics Corp.
since 2017.
Formerly, served as Chairman, President & Chief Executive Officer at Biocept, Inc. from 2022 to 2023.
Served as President, Chief Executive Officer & Director at Signal Genetics, Inc. from 2015 to 2017.
Served as President & Chief Executive Officer at Viridian Therapeutics, Inc. from 2014 to 2017.
Served as Chief Executive Officer at Cap Diagnostics LLC from 2019 to 2020.
Served as Chairman at Precipio Diagnostics LLC.
Served as Chairman at Precipio, Inc. from 2017 to 2019.
Served as Director at Transgenomic, Inc. Served as Director at BD Ventures LLC from 1995 to 2001.
Served as Director at Exagen, Inc. from 2011 to 2014.
Served as Vice President & General Manager at Becton, Dickinson & Co. from 1995 to 2001.
Served as General Manager at Puritan Bennett Corp.
from 1989 to 1994.
Served as Chief Operating Officer & Executive Vice President at Genoptix, Inc. from 2001 to 2011.
Education includes a graduate degree from The University of Texas at Austin in 1984 and an undergraduate degree from Washington & Jefferson College in 1981.